Table 1 Points of assessment and measures used
T0 Baseline | T1 Pre-test | T2 Midpoint | T3 Post-test | T4 Follow-up |
|---|---|---|---|---|
Approx. three months before start of treatment | At start of treatment | Approx. halfway through treatment | Immediately after treatment | Three months after treatment |
– CRIES | – CRIES | – CRIES | – CRIES | – CRIES |
– DSRS | – DSRS | – C-PTCI | – DSRS | – DSRS |
– SDQ | – SDQ | – TMQQ | – SDQ | – SDQ |
– C-PTCI | – C-PTCI | – SUDS (each session) | – C-PTCI | – C-PTCI |
– CYRM | – CYRM |  | – TMQQ | – TMQQ |
– TMQQ | – TMQQ |  | – CYRM | – CYRM |
– PDEQ |  |  | – CSRS | – CSRS |
For subsample: | Â | Â | Â | For subsample: |
– WMTB-C |  |  |  | – WMTB-C |
– RPM |  |  |  | – RPM |
– TMT |  |  |  | – TMT |